Shanna Mago
Psychiatric/Mental Health · Charlotte, NCNPI 1689918849
Payments from drug & device makers
Across 214 payments — averaging $25.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$911
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$748
- Alkermes, Inc.$504
- Otsuka America Pharmaceutical, Inc.$418
- Tris Pharma Inc$410
- Johnson & Johnson$343
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,433100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $911 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $748 |
| Alkermes, Inc. | 11 | $504 |
| Otsuka America Pharmaceutical, Inc. | 15 | $418 |
| Tris Pharma Inc | 21 | $410 |
| Johnson & Johnson | 7 | $343 |
| Supernus Pharmaceuticals, Inc. | 17 | $280 |
| Lundbeck LLC | 11 | $233 |
| E.r. Squibb & Sons, L.L.C. | 8 | $217 |
| Vanda Pharmaceuticals Inc. | 9 | $207 |
| Neos Therapeutics, LP | 9 | $193 |
| Noven Therapeutics, LLC | 10 | $191 |
| Teva Pharmaceuticals USA, Inc. | 3 | $156 |
| Corium, LLC | 7 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Collegium Pharmaceutical, Inc. | 4 | $90 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Almatica Pharma LLC | 4 | $76 |
| Avion Pharmaceuticals | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$899
- VRAYLAR$350
- SPRAVATO$234
- CAPLYTA$207
- UZEDY$114
- COBENFY$112
- Quillichew ER$107
- Quillivant$107
- Dyanavel XR$107
How this compares
$5,446 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 27 | $866 |
| Bupropion XlBupropion Hcl | 23 | $536 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 30 | $295 |
| Fluoxetine Hcl | 15 | $216 |
| Clonazepam | 13 | $119 |
| Alprazolam | 23 | $29 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Charlotte
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Carol Cameron MatthewsCharlotte$12K
- Rohan MatthewsCharlotte$8K
- Carli GastleyCharlotte$8K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.